Depression and extremes of blood pressure predict highest rates of harmful vascular events

August 29, 2015

London, UK - 29 Aug 2015: Depressive symptoms and extremes of blood pressure predict the highest rates of harmful vascular events in patients with existing heart disease, diabetes or stroke, according to research presented at ESC Congress today by Dr Bhautesh Jani, clinical academic fellow in the Institute of Health and Wellbeing, University of Glasgow, UK.1

The study in more than 35 000 patients found that the risk of further stroke or heart attack, heart failure or dying due to heart disease at four years was 83% higher in depressed patients with high blood pressure and 36% higher in depressed patients with low blood pressure, compared to those with normal blood pressure and no depressive symptoms.

"Previous studies have shown that patients with existing heart disease, diabetes or stroke are more likely to suffer from further heart attack or stroke than the general population, particularly those who have extremes of blood pressure or have depressive symptoms but until now the effects of having both together were unknown," said Dr Jani. "This is the first study which has specifically investigated the relationship between depressive symptoms and extreme blood pressure in influencing the rate of heart attack, stroke, heart failure and heart disease related deaths in patients with existing heart disease, diabetes or stroke."

The study included 35 537 community dwelling patients with existing heart disease, diabetes or stroke from Scotland, UK. In 2008-09 depression was assessed using the hospital anxiety and depression score (HADS-D). Systolic (SBP) and diastolic (DBP) blood pressure were recorded and patients were classified as very high (SBP>160, DBP>100), high (SBP 140-159, DBP 90-99), normal (SBP 130-139, DBP 80-89), tightly controlled (SBP 120-129, DBP 80-84) or low (SBP<120, DBP<80) blood pressure. The occurrence of major harmful events (further stroke or heart attack, heart failure or dying due to heart disease) was recorded over a period of four years.

During the four year follow up period 3 939 patients (11%) had a least one major harmful event. Depression had a significant interaction with SBP (p=0.03) in predicting a major harmful event. Dr Jani said: "The relationship between depression and blood pressure is an area of ongoing medical research and various physiological theories are under review to explain the nature of this relationship."

Patients with the combination of high blood pressure and depressive symptoms had 83% higher risk of a major harmful event at four years (hazard ratio (HR) =1.83; 95% confidence interval (CI) 1.46-2.30, p<<0.001) and those with low blood pressure and depressive symptoms had a 36% higher risk (HR=1.36; CI=1.15-1.62, p<0.001) than those with normal blood pressure and no depressive symptoms. The results were adjusted for factors that can influence risk of vascular events such as age, sex, body mass index (BMI), total cholesterol levels, socioeconomic status, use of antidepressants and the number of existing medical conditions.

"In our study, patients with a combination of depression and high or low blood pressure had the highest rate of a major harmful vascular event at four years," said Dr Jani. "One explanation for our results may be that these patients had the most severe form of existing heart disease, diabetes or stroke, which was not recognised and hence had the worst outcomes."

He concluded: "Our findings suggest that focusing resources on monitoring blood pressure and providing treatment in patients with associated depressive symptoms could improve health outcomes by reducing the risk of further strokes or heart attacks, having heart failure or dying from heart disease. They also indicate that patients with high or low blood pressure might benefit from screening and treatment for depression. To date there are no studies showing that treatment of depression changes or improves cardiovascular outcomes and more research is needed in this area. Studies are also needed to further understand how blood pressure and depression interact."
-end-


European Society of Cardiology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.